Skip to content

Anabolic properties of potato derived protein

Anabolic properties of potato derived protein

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON29643
Enrollment
24
Registered
2018-04-18
Start date
2018-04-17
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Muscle protein synthesis Potato Milk

Interventions

Single leg exercise, Milk versus Potato protein

Sponsors

Maastricht University (MUMC+)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Male - Aged 18-35 y inclusive - BMI 18.5 – 27.5 kg/m2 inclusive - Healthy recreationally active - Having given informed consent

Exclusion criteria

Exclusion criteria: - Allergies to milk proteins - Lactose intolerance - Smoking - Diagnosed diabetes - Diagnosed metabolic or intestinal disorders - A history of neuromuscular problems - Arthritic conditions - Any medications known to (or may) affect protein metabolism (i.e. corticosteroids, non-steroidal anti-inflammatories, or prescription strength acne medications). - Participation in a structured progressive (resistance) exercise program - Previous participation in a 13C amino acid tracer study within the last 1 year - Excessive alcohol use (>3 consumptions per day) - Drugs use in the last 3 months (or the test day needs to be scheduled minimal 3 months after last drugs use)

Design outcomes

Primary

MeasureTime frame
Muscle protein synthesis rates

Secondary

MeasureTime frame
Secondary outcome parameters include the early and late muscle protein synthetic response. Whole-body protein metabolism (synthesis, breakdown, oxidation, and net balance). Plasma amino acid concentrations

Contacts

Public ContactPhilippe Pinckaers

Maastricht University, Dep. Human Biology and Movement Sciences

philippe.pinckaers@maastrichtuniversity.nl0000000000000

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)